PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Phase of Trial: Phase III
Latest Information Update: 04 Nov 2019
Price : $35 *
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms PROTEST
- 15 Feb 2019 Planned number of patients changed from 1500 to 1100.
- 15 Feb 2019 Status changed from not yet recruiting to recruiting.
- 19 Sep 2018 Planned initiation date changed from 1 Jun 2018 to 1 Sep 2018.